Clinical trial
A Placebo Randomized Cross-Over Controlled Trial of Inulin Supplementation to Improve Cardiometabolic, Gut, and Vaginal Microbiome in Perimenopausal Women
NCT07724522 is registered in ClinicalTrials.gov with George Washington University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Placebo Randomized Cross-Over Controlled Trial of Inulin Supplementation to Improve Cardiometabolic, Gut, and Vaginal Microbiome in Perimenopausal Women
- Lead sponsor
- George Washington University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 1, 2026
- Completion date
- February 29, 2028
- Enrollment
- 27 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases (cvd), dietary fiber, gastrointestinal microbiome, insulin resistance, inulin, microbiota, muscle, skeletal, obesity & overweight, perimenopausal women, prebiotics, vascular health, women health